2024-02-22 22:36:10 ET
Gerresheimer AG (GRRMF)
Q4 2023 Earnings Conference Call
February 22, 2024 04:00 ET
Company Participants
Guido Pickert - Investor Relations
Dietmar Siemssen - Chief Executive Officer
Bernd Metzner - Chief Financial Officer
Conference Call Participants
Oliver Reinberg - Kepler Cheuvreux
Gaurav Jain - Barclays
Oliver Metzger - ODDO
Victoria Lambert - Berenberg
Falko Friedrichs - Deutsche Bank
David Adlington - JPMorgan
Sven Kuerten - DZ Bank
James Vane-Tempest - Jefferies
Presentation
Guido Pickert
Let me quickly introduce myself as this is my first earnings call with Gerresheimer since I recently joined the company in January.
I personally started my career in Investor Relations in the late ‘90s. In 2007, I joined Aixtron, a supplier to the semiconductor industry. After 67 quarterly earnings calls there, I’m very happy having recently become a member of the Gerresheimer family, expanding that number even further with #68 today. I’m looking forward meeting many of you in due course.
With that, I hand over to our CEO, Dietmar Siemssen, to run you through the highlights of the quarter and full year 2023, together with our CFO, Dr. Bernd Metzner. Dietmar?
Dietmar Siemssen
Yes. Thank you, Guido, and welcome, everybody. Thank you for joining us this morning. Bernd Metzner, our CFO, and I will now run you through the highlights of the fourth quarter and, of course, the full year results 2023. As always, we will be then happy to take your questions.
Implementing our strategy process formula G has proved to be a success story. Gerresheimer has successfully been transformed to an innovative system, a solution provider and the strategic partner of choice for the global pharma and biotech industry. We are a key partner of our customers. Our products are essential for an effective drug therapy and positive results....
Read the full article on Seeking Alpha
For further details see:
Gerresheimer AG (GRRMF) Q4 2023 Earnings Call Transcript